2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$16.25-$0.07 (-0.46%)
Price as of Aug 21, 2026 7:30 PM EDT- $18.5BMarket Cap
- 58.67%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$16.25-$0.07 (-0.46%)
VTRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.32 | ||
Change | +$0.32 (+2.00%) | ||
Open | $16.01 | ||
High | $16.37 | ||
Low | $15.98 | ||
Previous Close | $16.12 | ||
Volume | 6,494,519 | ||
30-Day Average Volume | 10,525,384 | ||
1-Week Change | 1.31% | ||
1-Month Change | -6.52% | ||
1-Year Change | 58.67% | ||
3-Year Change | 66.34% | ||
5-Year Change | 38.13% | ||
Fundamentals | |||
Shares Outstanding | 1.1B | ||
Total Assets | $35.0B | ||
Market Cap | $18.5B | ||
Enterprise Value | $31.0B | ||
Period: QTR TTM FY | |||
Revenue | $3.8B | ||
Net Income | -$118.8M | ||
Free Cash Flow | $329.0M | ||
EBIT | $56.7M | ||
EBITDA | $729.0M | ||
Net Working Capital | $3.7B | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | 42 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 1 | ||
P/E | -163 | ||
PEG | 1 | ||
Price/Free Cash Flow | 57 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.94% | ||
Trailing Annual Dividend Yield | 3.68% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield